A Review of: "Preclinical Drug Development"

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.33, Iss.4, 2007-04, pp. : 493-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabonomics in preclinical drug development

By Robertson Donald G Reily Michael D Baker J David

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

Preclinical drug development for childhood cancer

By Moreno Lucas Chesler Louis Hargrave Darren Eccles Suzanne A Pearson Andrew DJ

Expert Opinion on Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 49-64

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in preclinical drug development in multiple sclerosis

By Hoban C.J.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 831-854

Informa Healthcare

Access to resources Recommend Favorite

Positron Emitting Tracers in Pre-Clinical Drug Development

Current Radiopharmaceuticals, Vol. 5, Iss. 2, 2012-04 ,pp. : 90-98

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Development of Low Toxicity Drugs: Focus on Zanamivir, an Anti-Influenza Drug

By Dines G.D.

Drug Safety, Vol. 19, Iss. 3, 1998-09 ,pp. : 233-241

Adis International

Access to resources Recommend Favorite